Dissecting the Molecular and Cellular Pathophysiology of Sarcopenic Obesity in the Elderly
Ageing is characterised by a change in body composition with a parallel decrease in muscle mass and an increase and central redistribution of fat. When drastically exacerbated, these two processes culminate in a condition known as sarcopenic obesity (SO). SO is characterised by the coexistence of obesity and sarcopenia
| Condition(s) | Sarcopenic Obesity |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Ageing is characterised by a change in body composition with a parallel decrease in muscle mass and an increase and central redistribution of fat. When drastically exacerbated, these two processes culminate in a condition known as sarcopenic obesity (SO). SO is characterised by the coexistence of obesity and sarcopenia (i.e. reduced muscle mass and function) and is a growing public health problem in the elderly. The health risks of obesity and sarcopenia act synergistically, maximising the risk of disability of OS. The molecular mechanisms underlying OS are largely unknown. Increased fat mass induces chronic systemic inflammation and alters the profiles of adipokines and hormones, promoting the development of sarcopenia. On the other hand, the reduction in muscle tissue (SM) typical of sar |
| Who can participate | Inclusion Criteria: patients who are candidates for hip surgery * patients who are candidates for hip surgery * age ≥ 65 years * patients able to give consent healthy subjects \- healthy subjects from the geriatric cohort studied in 2016-2017 who at that time were: were overweight (25 ≤ BMI \< 30 kg/m2) or obese (BMI ≥ 30 kg/m2) but had not yet developed sarcopenia Exclusion Criteria: All partecipants * unavailability to participate in the study * inflammatory or neurological myopathies * acute heart failure * active cancer |
| Ages | 65 Years to 99 Years |
| Sex | All |
| Lead sponsor | IRCCS San Raffaele |
| Locations | Milan, Italy |
| Start date | 2023-05-22 |
| NCT ID | NCT06320158 |
| Official listing | https://clinicaltrials.gov/study/NCT06320158 |